ENHANCED RELEASE OF ENDOTHELIUM-DERIVED FACTOR(S) BY CHRONIC INCREASES IN BLOOD-FLOW

被引:191
作者
MILLER, VM
VANHOUTTE, PM
机构
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1988年 / 255卷 / 03期
关键词
D O I
10.1152/ajpheart.1988.255.3.H446
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
引用
收藏
页码:H446 / H451
页数:6
相关论文
共 31 条
[1]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[2]   ANTAGONIST DISCRIMINATION BETWEEN GANGLIONIC AND ILEAL MUSCARINIC RECEPTORS [J].
BROWN, DA ;
FORWARD, A ;
MARSH, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1980, 71 (02) :362-364
[3]   THE AFFINITY OF SOME SELECTIVE MUSCARINIC RECEPTOR ANTAGONISTS FOR THE MUSCARINIC RECEPTOR MEDIATING ENDOTHELIAL-DEPENDENT RELAXATION OF THE RABBIT AND RAT THORACIC AORTA [J].
CHOO, LK ;
MALTA, E ;
MITCHELSON, F .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1986, 38 (11) :843-845
[4]   ACTION OF AGONISTS AND ANTAGONISTS AT MUSCARINIC RECEPTORS PRESENT ON ILEUM AND ATRIA INVITRO [J].
CLAGUE, RU ;
EGLEN, RM ;
STRACHAN, AC ;
WHITING, RL .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 86 (01) :163-170
[5]   INFLUENCE OF HEMODYNAMIC FORCES ON VASCULAR ENDOTHELIAL FUNCTION - INVITRO STUDIES OF SHEAR-STRESS AND PINOCYTOSIS IN BOVINE AORTIC-CELLS [J].
DAVIES, PF ;
DEWEY, CF ;
BUSSOLARI, SR ;
GORDON, EJ ;
GIMBRONE, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (04) :1121-1129
[6]  
EGLEN RM, 1985, BRIT J PHARMACOL, V84, P3
[7]   STIMULATION OF SOLUBLE GUANYLATE-CYCLASE BY AN ACETYLCHOLINE-INDUCED ENDOTHELIUM-DERIVED FACTOR FROM RABBIT AND CANINE ARTERIES [J].
FORSTERMANN, U ;
MULSCH, A ;
BOHME, E ;
BUSSE, R .
CIRCULATION RESEARCH, 1986, 58 (04) :531-538
[8]   FLOW EFFECTS ON PROSTACYCLIN PRODUCTION BY CULTURED HUMAN-ENDOTHELIAL CELLS [J].
FRANGOS, JA ;
ESKIN, SG ;
MCINTIRE, LV ;
IVES, CL .
SCIENCE, 1985, 227 (4693) :1477-1479
[9]   THE OBLIGATORY ROLE OF ENDOTHELIAL-CELLS IN THE RELAXATION OF ARTERIAL SMOOTH-MUSCLE BY ACETYLCHOLINE [J].
FURCHGOTT, RF ;
ZAWADZKI, JV .
NATURE, 1980, 288 (5789) :373-376
[10]  
FURCHGOTT RF, 1984, TRENDS PHARM SCI S, V5, P45